COPD and lung cancer share similar risk factors, disease processes, and symptoms. They are both also significant causes of morbidity and mortality: nearly 16 million people in the US are living with COPD, and lung cancer is the second most common cancer in both men and women in the US, accounting for about 20% of all cancer deaths.
Patients with COPD are at higher risk of developing lung cancer. COPD in patients with lung cancer is associated with lower survival rates.
In 2021, the United States Preventive Services Task Force (USPSTF) expanded their recommended lung cancer screening-eligible population, and in 2022 CMS updated their coverage determination to match the USPSTF recommendation more closely.
Early-stage detection of lung cancer improves prognosis — when caught before it spreads, 5-year survival likelihood improves to 63%. We therefore urge you to screen all eligible patients for lung cancer, especially those who have COPD.
|